pyrroles has been researched along with suramin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bott, A; Eltze, M; Illes, P | 1 |
| Bianchi, L; Boselli, C; Grana, E | 1 |
| Biasoli, G; Borgia, AL; Botta, M; Cappello, V; Ciomei, M; Corelli, F; Manetti, F; Mongelli, N | 1 |
| De Godoy, M; Li, F; Rattan, S | 1 |
| Khoo, CP; Micklem, K; Watt, SM | 1 |
| Bajorin, DF; Bosl, GJ; Carousso, M; Feldman, DR; Ginsberg, MS; Motzer, RJ; Patil, S; Sheinfeld, J; Trinos, MJ | 1 |
| Amobi, NI; Guillebaud, J; Smith, IC | 1 |
7 other study(ies) available for pyrroles and suramin
| Article | Year |
|---|---|
External ATP antagonizes the effect of potassium channel openers in guinea-pig ventricular papillary muscle.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Electric Stimulation; Glyburide; Guinea Pigs; Male; Myocardial Contraction; Papillary Muscles; Potassium Channels; Pyridines; Pyrroles; Suramin | 1992 |
Cromakalim blocks the purinergic response evoked in rat vas deferens by single-pulse electrical stimulation.
Topics: Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Electric Stimulation; Glyburide; Male; Norepinephrine; Potassium Channels; Prazosin; Pyrroles; Rats; Rats, Wistar; Suramin; Vas Deferens | 1997 |
Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor.
Topics: 3T3 Cells; Allantois; Animals; Antineoplastic Agents; Chorion; Drug Screening Assays, Antitumor; Fibroblast Growth Factor 2; Humans; In Vitro Techniques; Ligands; Mice; Models, Molecular; Naphthalenes; Neovascularization, Pathologic; Pyrazoles; Pyrroles; Structure-Activity Relationship; Suramin | 1998 |
Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle.
Topics: Adenine; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting, Western; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; GTP-Binding Proteins; Guanylate Cyclase; Indoles; Male; Muscle Relaxation; Muscle, Smooth; Oxadiazoles; Procaterol; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Suramin; Xamoterol | 2004 |
A comparison of methods for quantifying angiogenesis in the Matrigel assay in vitro.
Topics: Angiogenesis Inhibitors; Biological Assay; Collagen; Colony-Forming Units Assay; Drug Combinations; Endothelial Cells; Endothelium, Vascular; Fetal Blood; Humans; Image Processing, Computer-Assisted; Indoles; Intercellular Signaling Peptides and Proteins; Laminin; Neovascularization, Physiologic; Oxindoles; Phenotype; Propionates; Proteoglycans; Pyrroles; Software; Suramin | 2011 |
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Endpoint Determination; Female; Humans; Indoles; Kaplan-Meier Estimate; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Pyrroles; Retroperitoneal Neoplasms; Retrospective Studies; Sunitinib; Suramin; Testicular Neoplasms; Topotecan; Treatment Outcome; Young Adult | 2012 |
Perspective on the role of P2X-purinoceptor activation in human vas deferens contractility.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Amides; Apamin; Calcium Channel Agonists; Calcium Channels, L-Type; Humans; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Contraction; Norepinephrine; Peptides; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Purinergic P2X Receptor Agonists; Pyridines; Pyrophosphatases; Pyrroles; Receptors, Purinergic P2X; rho-Associated Kinases; Suramin; Vas Deferens | 2012 |